Details for Patent: 8,017,150
✉ Email this page to a colleague
Summary for Patent: 8,017,150
| Title: | Polyethylene oxide-based films and drug delivery systems made therefrom |
| Abstract: | The invention relates to the film products and methods of their preparation that demonstrate a non-self-aggregating uniform heterogeneity. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. The films contain a polymer component, which includes polyethylene oxide optionally blended with hydrophilic cellulosic polymers. Desirably, the films also contain a pharmaceutical and/or cosmetic active agent with no more than a 10% variance of the active agent pharmaceutical and/or cosmetic active agent per unit area of the film. |
| Inventor(s): | Yang; Robert K. (Flushing, NY), Fuisz; Richard C. (McLean, VA), Myers; Garry L. (Kingsport, TN), Fuisz; Joseph M. (Washington, DC) |
| Assignee: | MonoSol Rx, LLC (Portage, IN) |
| Application Number: | 12/107,389 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,017,150 |
|
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 8,017,150
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
